-
03 September 2020
Conversation with Francoise Vanni (in Italian) With Françoise Vanni, Head of External Relations and Communications at the Global Fund
-
10 August 2020
An Effective Global Response to COVID-19 will Require Unprecedented Levels of Collaboration, Innovation and Money - By Peter Sands, Executive Director of the Global Fund
-
30 July 2020
COVID and the Big Three With Urban Weber, Head of High Impact Asia Department at the Global Fund
-
13 July 2020
The "Huge Amount at Stake" for HIV Progress With Peter Sands, Executive Director of the Global Fund
-
13 July 2020
HIV, Tuberculosis, and Malaria: How can the Impact of COVID-19 be Minimised? - By Peter Sands, Executive Director of the Global Fund
-
02 July 2020
Out of Tragedy Comes Opportunity: How Can Global Health Multilateralism Seize the Moment? - By Julia Kaufman, Alexander Winch, Shu-Shu Tekle-Haimanot, and Kalipso Chalkidou
-
27 June 2020
We Must Unite to Fight or We Will Lose Years of Progress (in Italian) - By Peter Sands, Executive Director of the Global Fund
-
10 June 2020
In Kenya, A Chance to See Communities Confront COVID-19
By Ernest Waititu, Staff at the Global Fund
It feels like a year ago now. But it was on 19 March, when I left for my hometown of Nairobi from Geneva, where I live and work. I landed in Nairobi on the morning of 20 March, a week after Kenya had confirmed its first case of the coronavirus and a ... -
27 May 2020
COVID-19 Threatens to Derail Fight Against HIV, TB and Malaria
By Peter Sands, Executive Director of the Global Fund
As COVID-19 ravages the world, the fight against HIV, TB and malaria is acutely at risk. That fight is not merely at risk of getting knocked off course – it can be derailed entirely. -
12 May 2020
Amid COVID-19, Communities Continue Fight against Other Pandemics
By Linda Mafu, Head of Political and Civil Society Advocacy at the Global Fund
At the International AIDS conference in 2000 I joined an activist community that barreled through the streets of Durban demanding universal access to HIV treatment. At the time, the treatment was only accessible to the rich – it cost more than US$10,...